A. Scott

OverviewAI-generated summary

A. Scott's research program focuses on vector-borne infectious diseases, particularly those caused by Borrelia species. A significant portion of this work has been supported by National Institutes of Health (NIH) grants from the National Institute of Allergy and Infectious Diseases. These grants have funded investigations into the genetic manipulation of Borrelia duttonii, the causative agent of Old World tick-borne relapsing fever, and the role of cyclic di-AMP and cyclic di-GMP second messenger signaling pathways in various tick-borne relapsing fever Borrelia species, including Borrelia turicatae.

In addition to work on bacterial pathogens, Scott's recent publications indicate an interest in public health topics, including vaccine hesitancy among parents of pediatric patients and the associations between COVID-19 death exposure, vaccine hesitancy, and vaccine uptake. Further research has explored the conversion of Letermovir for primary Cytomegalovirus (CMV) prophylaxis in transplant patients. Scott collaborates with researchers at the University of Arkansas for Medical Sciences, including James Selig, Lawrence E. Cornett, and Brett Rowland.

Metrics

• h-index: 2
• Publications: 9
• Citations: 6